It has previously been shown that in vivo neutralization of CCL21 could prevent human DC migration to the cervical lymph nodes in mucocutaneous lymph node syndrome in humanized severe combined immunodeficient mice and the subsequent development of asthma features (17). This evidence concerns the gene CCL21 and Kawasaki disease.